Wellcome Open ResearchMicrobiologyPeer-reviewed journal article
Complete assembly of a dengue virus type 3 genome from a recent genotype III clade by metagenomic sequencing of serum
C. Pattabiraman, M. Dias, S. Siddappa, M. Gowda, A. Shet, D. Smith, B. Muehlemann, K. Tamma, T. Solomon, T. Jones, S. Krishna
Abstract
BackgroundMosquito-borne flaviviruses causing diseases such as dengue and Japanese encephalitis are devastating, particularly in the tropics. Although, multiple flaviviruses are known to co-circulate in India, when a patient presents with febrile illness, testing is usually limited to specific pathogens. Unbiased metagenomic sequencing of febrile cases can reveal the presence of multiple pathogens and provide complete genome information. Sequence information, a cornerstone for tracing virus evolution, is relevant for the design of vaccines and therapeutics. In order to assess the usefulness of unbiased metagenomic sequencing for the identification of viruses associated with febrile illness, we sequenced serum from four individuals and plasma from one individual, all hospitalized at a tertiary care centre in South India with severe or prolonged febrile illnesses, together with one healthy control in 2014.\n\nResultsWe identified and assembled a complete dengue virus type 3 (DENV3) sequence from the serum of a case classified as severe dengue. We also found a small number of Japanese encephalitis virus (JEV) sequences in the serum of two adults with febrile illness, including the one who had dengue. Phylogenetic analysis of the dengue sequence indicates that it belongs to a predominantly Asian, DENV3, genotype III clade. It had an estimated divergence time of 13.86 years (95% Highest Posterior Densities 12.94 - 14.83 years) with the closest Indian strain. Amino acid substitutions were present throughout the sequenced genome, including 11 substitutions in the antigenic envelope protein compared to the strain used for the development of the first commercial dengue vaccine. Of these one substitution (E361D) was unique and six were in critical antigenic sites.\n\nConclusionsWe demonstrate that both genome assembly and detection of a low number of viral sequences are possible by unbiased sequencing of clinical material. Complete dengue virus sequence analysis places the sequenced genome in a recent, predominantly Asian clade within genotype III of DENV3. The detection of JEV, an agent not routinely tested in febrile illness in India, warrants further analysis and highlights the need to study co-circulating flaviviruses in parallel.
- organism: virus
- assay: metagenomics
- research focus: genome assembly
- research focus: variant calling
- research focus: phylogenetics / evolution
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Co-circulation of Dengue Virus Serotypes 1 and 3 during the 2019 epidemic in Dar es Salaam, Tanzania
Gaspary Mwanyika, Leonard E. G. Mboera, … Gerald Misinzo·bioRxiv·Sep 9, 2019
- Dengue Virus Surveillance in Nepal Yields the First On-Site Whole Genome Sequences of Isolates from the 2022 Outbreak
Rajindra Napit, Annie Elong Ngono, … Krishna Das Manandhar·BMC GenomicsPeer-reviewed·Oct 24, 2024
- Genomic sequencing and neutralizing serological profiles during acute dengue infection: A 2017 cohort study in Nepal
Sabita Prajapati, Annie Elong Ngono, … Krishna Das Manandhar·PLOS Global Public HealthPeer-reviewed·Nov 13, 2024
- Simultaneous circulation and coinfection of Dengue clades and serotypes in Southern Brazil
Thales de Lima Bermann, Ludmila Fiorenzano Baethgen, … Richard Steiner Salvato·bioRxiv·Feb 24, 2024
- Evidence for recombination in dengue virus genomes
Hugo de Paula Oliveira, Denis Jacob Machado, … Kary Ocaña·bioRxiv·Jun 16, 2026
- Assessment of Metagenomic MinION and Illumina sequencing as an approach for the recovery of whole genome sequences of chikungunya and dengue viruses directly from clinical samples.
L. E. Kafetzopoulou, K. Efthymiadis, … S. T. Pullan·bioRxiv·Jun 25, 2018